发明申请
US20110177028A1 INTERFERON-BETA AND/OR LAMBDA FOR USE IN TREATING RHINOVIRUS INFECTION IN THE ELDERLY
审中-公开

基本信息:
- 专利标题: INTERFERON-BETA AND/OR LAMBDA FOR USE IN TREATING RHINOVIRUS INFECTION IN THE ELDERLY
- 专利标题(中):用于治疗老年性恶病毒感染的干扰素和/或LAMBDA
- 申请号:US13007541 申请日:2011-01-14
- 公开(公告)号:US20110177028A1 公开(公告)日:2011-07-21
- 发明人: Donna DAVIES , Sarah Margaret PUDDICOMBE , Soo-Wei FOO
- 申请人: Donna DAVIES , Sarah Margaret PUDDICOMBE , Soo-Wei FOO
- 主分类号: A61K38/21
- IPC分类号: A61K38/21 ; A61K48/00 ; A61K31/7088 ; A61K31/403 ; A61P31/14
摘要:
Use of interferon-beta (IFN-β) and/or IFN-λ for treating rhinovirus (RV) infection in elderly people, particularly elderly people who are, or have been long-term smokers, especially those who have a clinical history of recurrent RV infections, and may have other medical conditions, such as cardiac or circulation problems, and who are liable to suffer severe complications/high mortality from poor innate ability to fight such a viral infection.
摘要(中):
干扰素-β(IFN-和bgr)和/或IFN-λ用于治疗老年人,特别是长期吸烟者或长期吸烟者的老年人的鼻病毒(RV)感染的用途,特别是具有临床病史 复发性RV感染,并可能有其他医疗状况,例如心脏或循环问题,以及谁可能遭受严重并发症/高死亡率,因为这种病毒感染的天生能力较差。
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K38/00 | 含肽的医药配制品 |
--------A61K38/04 | .在完全确定的序列中最多有20个氨基酸的肽;其衍生物 |
----------A61K38/17 | ..来源于动物;来源于人类 |
------------A61K38/19 | ...细胞因子;淋巴因子;干扰素 |
--------------A61K38/21 | ....干扰素 |